S&P 500 · セクター · 60社
S&P 500のヘルスケア株
直近の会計年度で、このセクターの企業の売上高の合計は$3.66兆、純利益は$1,960億(売上高の5.4%)でした。売上高が最大の企業はUnitedHealth Groupです。
直近の会計年度の売上高の合計、60社
$3.66兆年率+9.1%
10年間の売上高成長率の中央値(53社)
企業
60
サブ産業:10
純利益の合計
$1,960億
売上高は5.4%
純利益率の中央値
13.0%
直近の会計年度
配当を支払う企業
60のうち37
データ上、毎年増配:7社
10年前より株式数が減少
57のうち31
変化の中央値は−5.8%
2010年以降の売上高と純利益の合計
全期間の数値がある企業(48社)の売上高は、2010年の$9,800億から2025年の$3.33兆になりました(年率8.5%)。
売上高純利益
チャートのデータを読み込めませんでした。下の表に同じ数値があります。
企業
| UnitedHealth Group | UNH | Managed Health Care | 2025 | $4,480億 | $121億 | 2.7% | 11.7% | 11.0% | 8.2% | $8.73 | 16 | −5.8% |
| McKesson | MCK | Health Care Distributors | 2026 | $4,030億 | $47.6億 | 1.2% | 11.1% | 7.8% | 14.7% | $3.17 | 13 | −46.7% |
| CVS Health | CVS | Health Care Services | 2025 | $4,020億 | $17.7億 | 0.4% | 8.4% | 10.1% | −11.3% | $2.66 | 0 | +12.9% |
| COR | Health Care Distributors | 2025 | $3,210億 | $15.5億 | 0.5% | 11.1% | 9.0% | — | $2.20 | 17+ | −10.4% | |
| Cigna | CI | Health Care Services | 2025 | $2,750億 | $59.6億 | 2.2% | 11.4% | 21.9% | 10.7% | $6.04 | 5 | +3.1% |
| CAH | Health Care Distributors | 2026 | $2,540億 | $17.1億 | 0.7% | 9.4% | 7.7% | 5.3% | $2.04 | 18+ | −28.2% | |
| ELV | Managed Health Care | 2025 | $1,990億 | $56.6億 | 2.8% | 10.3% | 9.7% | 10.4% | $6.84 | 14 | −17.7% | |
| CNC | Managed Health Care | 2025 | $1,950億 | −$66.7億 | −3.4% | 11.9% | 23.9% | — | — | — | +100.3% | |
| HUM | Managed Health Care | 2025 | $1,300億 | $11.9億 | 0.9% | 10.9% | 9.1% | 1.5% | $3.54 | 0 | −20.1% | |
| Johnson & Johnson | JNJ | Pharmaceuticals | 2025 | $942億 | $268億 | 28.5% | 2.7% | 3.0% | 7.2% | $5.14 | 18+ | −13.6% |
| HCA | Health Care Facilities | 2025 | $756億 | $67.8億 | 9.0% | 8.0% | — | 19.0% | $2.88 | 5 | −43.9% | |
| LLY | Pharmaceuticals | 2025 | $652億 | $206億 | 31.7% | 21.6% | 12.6% | 26.1% | $6.23 | 9 | −15.6% | |
| MRK | Pharmaceuticals | 2025 | $650億 | $183億 | 28.1% | 9.4% | 5.1% | 16.7% | $3.28 | 15 | −11.8% | |
| PFE | Pharmaceuticals | 2025 | $626億 | $77.7億 | 12.4% | 8.5% | 2.5% | 2.1% | $1.72 | 15 | −8.7% | |
| ABBV | Biotechnology | 2025 | $612億 | $42.3億 | 6.9% | 6.0% | 10.3% | −2.8% | $6.65 | 11 | +8.3% | |
| BMY | Pharmaceuticals | 2025 | $482億 | $70.5億 | 14.6% | 2.5% | 11.3% | 14.0% | $2.49 | 18+ | +21.4% | |
| TMO | Life Sciences Tools & Services | 2025 | $446億 | $67億 | 15.0% | 6.7% | 10.1% | 13.7% | $1.72 | 8 | −6.0% | |
| ABT | Health Care Equipment | 2025 | $443億 | $65.2億 | 14.7% | 5.1% | 8.1% | 2.5% | $2.40 | 3 | +16.1% | |
| AMGN | Biotechnology | 2025 | $368億 | $77.1億 | 21.0% | 7.6% | 5.4% | 4.6% | $9.66 | 12 | −29.2% | |
| MDT | Health Care Equipment | 2026 | $364億 | $48億 | 13.2% | 3.8% | 2.3% | 4.2% | $2.84 | 18+ | −9.7% | |
| Gilead Sciences | GILD | Biotechnology | 2025 | $294億 | $85.1億 | 28.9% | 3.6% | −1.0% | −5.5% | $3.16 | 10 | −17.5% |
| SYK | Health Care Equipment | 2025 | $251億 | $32.5億 | 12.9% | 11.8% | 9.7% | 8.3% | $3.40 | 16 | +1.5% | |
| DHR | Life Sciences Tools & Services | 2025 | $246億 | $36.1億 | 14.7% | 2.0% | — | 0.6% | — | — | +1.1% | |
| BDX | Health Care Equipment | 2025 | $218億 | $16.8億 | 7.7% | 6.3% | 7.8% | 5.7% | $4.16 | 12 | +39.0% | |
| GE HealthCare | GEHC | Health Care Equipment | 2025 | $206億 | $20.8億 | 10.1% | — | — | — | $0.14 | 2+ | — |
| BSX | Health Care Equipment | 2025 | $201億 | $29億 | 14.4% | 15.2% | 10.4% | — | — | — | +11.4% | |
| UHS | Health Care Facilities | 2025 | $174億 | $14.9億 | 8.6% | 8.5% | 6.7% | 13.1% | $0.80 | 0 | −36.0% | |
| IQV | Life Sciences Tools & Services | 2025 | $163億 | $13.6億 | 8.3% | 7.5% | 11.0% | 9.8% | — | — | +38.1% | |
| Regeneron Pharmaceuticals | REGN | Biotechnology | 2025 | $143億 | $45億 | 31.4% | 11.0% | 13.3% | 22.3% | $3.52 | 0 | −5.8% |
| VTRS | Pharmaceuticals | 2025 | $143億 | −$35.1億 | −24.6% | 3.7% | 4.3% | — | $0.48 | 0 | +134.6% | |
| Labcorp | LH | Health Care Services | 2025 | $140億 | $8.77億 | 6.3% | −0.0% | 4.9% | 9.2% | $2.88 | 0 | −16.7% |
| DVA | Health Care Services | 2025 | $136億 | $7.47億 | 5.5% | 3.4% | — | 22.9% | — | — | −64.9% | |
| Henry Schein | HSIC | Health Care Distributors | 2025 | $132億 | $3.98億 | 3.0% | 5.4% | — | 1.4% | — | — | −27.7% |
| VRTX | Biotechnology | 2025 | $120億 | $39.5億 | 32.9% | 14.1% | 27.8% | — | — | — | +6.9% | |
| BAX | Health Care Equipment | 2025 | $112億 | −$9.57億 | −8.5% | −0.7% | 1.2% | — | $0.52 | 0 | −6.6% | |
| Quest Diagnostics | DGX | Health Care Services | 2025 | $110億 | $9.92億 | 9.0% | 3.2% | 3.9% | 6.0% | $3.20 | 15 | −22.1% |
| ISRG | Health Care Equipment | 2025 | $101億 | $28.6億 | 28.4% | 18.2% | 15.5% | 16.4% | — | — | +6.3% | |
| Biogen | BIIB | Biotechnology | 2025 | $98.9億 | $12.9億 | 13.1% | −6.0% | −0.8% | −5.4% | — | — | −36.4% |
| ZTS | Pharmaceuticals | 2025 | $94.7億 | $26.7億 | 28.2% | 7.2% | 7.1% | 24.4% | $2.03 | 12 | −11.6% | |
| SOLV | Health Care Technology | 2025 | $83.2億 | $15.6億 | 18.7% | — | — | — | — | — | — | |
| ZBH | Health Care Equipment | 2025 | $82.3億 | $7.05億 | 8.6% | 6.1% | 3.2% | 16.5% | $0.96 | 0 | +4.7% | |
| A | Life Sciences Tools & Services | 2025 | $69.5億 | $13億 | 18.8% | 5.4% | 5.6% | 14.3% | $0.99 | 10 | −14.9% | |
| EW | Health Care Equipment | 2025 | $60.7億 | $10.7億 | 17.7% | 6.7% | 9.3% | 9.3% | — | — | −11.4% | |
| STE | Health Care Equipment | 2026 | $59.4億 | $7.82億 | 13.2% | 13.8% | 10.2% | 17.7% | $2.46 | 15 | +38.7% | |
| RMD | Health Care Equipment | 2026 | $56.5億 | $15.2億 | 26.9% | 12.1% | 11.9% | 15.4% | $2.40 | 5 | +3.1% | |
| INCY | Biotechnology | 2025 | $51.4億 | $12.9億 | 25.0% | 14.0% | 21.2% | 71.0% | — | — | +7.2% | |
| Dexcom | DXCM | Health Care Equipment | 2025 | $46.6億 | $8.36億 | 17.9% | 19.3% | 27.8% | — | — | — | +27.0% |
| ILMN | Life Sciences Tools & Services | 2025 | $43.4億 | $8.5億 | 19.6% | 6.0% | 6.9% | 5.8% | — | — | +4.7% | |
| IDXX | Health Care Equipment | 2025 | $43億 | $10.6億 | 24.6% | 9.7% | 10.4% | 20.4% | — | — | −13.5% | |
| COO | Health Care Supplies | 2025 | $40.9億 | $3.75億 | 9.2% | 11.0% | 8.6% | 6.1% | — | — | +1.6% | |
| ALGN | Health Care Supplies | 2025 | $40.3億 | $4.1億 | 10.2% | 10.3% | 16.9% | 12.3% | — | — | −11.0% | |
| MTD | Life Sciences Tools & Services | 2025 | $40.3億 | $8.69億 | 21.6% | 5.5% | 5.3% | 12.9% | — | — | −26.9% | |
| CRL | Life Sciences Tools & Services | 2025 | $40.2億 | −$1.44億 | −3.6% | 6.5% | 11.4% | — | — | — | +4.1% | |
| VEEV | Health Care Technology | 2026 | $32億 | $9.09億 | 28.4% | 16.9% | 22.8% | 30.5% | — | — | +15.2% | |
| Waters Corporation | WAT | Life Sciences Tools & Services | 2025 | $31.7億 | $6.43億 | 20.3% | 6.0% | 4.5% | 6.7% | — | — | −28.1% |
| West Pharmaceutical Services | WST | Health Care Supplies | 2025 | $30.7億 | $4.94億 | 16.1% | 7.4% | 8.2% | 18.0% | $0.86 | 17+ | −1.5% |
| RVTY | Health Care Equipment | 2025 | $28.6億 | $2.41億 | 8.4% | 1.4% | 3.1% | 1.0% | $0.28 | 0 | +2.9% | |
| Insulet Corporation | PODD | Health Care Equipment | 2025 | $27.1億 | $2.47億 | 9.1% | 24.5% | 26.2% | — | — | — | +26.6% |
| MRNA | Biotechnology | 2025 | $19.4億 | −$28.2億 | −145.2% | 19.3% | — | — | — | — | — | |
| Bio-Techne | TECH | Life Sciences Tools & Services | 2026 | $12.2億 | $1.82億 | 15.0% | 5.5% | 9.3% | 5.2% | $0.32 | 0 | +5.2% |
売上高と純利益:直近の通期の会計年度(FY)。成長率:5年または10年の年平均成長率。配当:直近の年の1株当たり配当。連続増配:1株当たり配当が前年を上回った年が続いた年数。SECのデータは2009年から始まる(2007〜2008年は比較用の年)ため、+は企業の数値が始まる時点まで連続増配がさかのぼることを示します。株式数(10年):株式数の変化で、マイナスは自社株買いを意味します。—:データにない、または意味をなさない。
その他のセクター
出典:SEC EDGAR(企業の提出書類)、2026年11月13日時点のデータ。 セクター、サブ産業、本社所在地、指数採用日:Wikipedia、CC BY-SA 4.0。